{"id":"NCT03945019","sponsor":"Celltrion","briefTitle":"CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease (LIBERTY-CD)","officialTitle":"A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study to Evaluate the Efficacy and Safety of the Subcutaneous Injection of CT-P13 (CT-P13 SC) as Maintenance Therapy in Patients With Moderately to Severely Active Crohn's Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-10-28","primaryCompletion":"2022-08-23","completion":"2023-08-22","firstPosted":"2019-05-10","resultsPosted":"2023-10-23","lastUpdate":"2023-10-23"},"enrollment":396,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Crohn's Disease"],"interventions":[{"type":"BIOLOGICAL","name":"CT-P13 SC (Infliximab)","otherNames":[]},{"type":"OTHER","name":"Placebo SC","otherNames":[]}],"arms":[{"label":"CT-P13 SC","type":"EXPERIMENTAL"},{"label":"Placebo SC","type":"PLACEBO_COMPARATOR"}],"summary":"This is Phase 3, Randomized, Placebo-controlled study to demonstrate superiority of CT-P13 SC over Placebo SC in Patients With Moderately to Severely Active Crohn's Disease","primaryOutcome":{"measure":"Percentage of Patients Achieving Clinical Remission (Based on CDAI) at Week 54","timeFrame":"Week 54","effectByArm":[{"arm":"CT-P13 SC 120 mg","deltaMin":144,"sd":null},{"arm":"Placebo","deltaMin":36,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":2},"locations":{"siteCount":29,"countries":["United States","Belarus","Bulgaria","Croatia","Czechia","France","Germany","Greece","Hungary","India","Israel","Italy","Japan","Latvia","Mexico","Moldova","Peru","Poland","Romania","Russia","Serbia","Slovakia","South Africa","Spain","Turkey (TÃ¼rkiye)","Ukraine"]},"refs":{"pmids":["40243842","38788861"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":12,"n":396},"commonTop":["COVID-19","Headache","Crohn's disease","Anaemia","Injection site reaction"]}}